 clinical pharmacology etoposide Etoposide semisynthetic derivative podophyllotoxin cancer Etoposide phase-specific cytotoxic drug late early phases cell cycle breaks DNA interaction DNA-topoisomerase II formation free radicals studies biexponential decay intravenous IV administration etoposide peak plasma concentrations drug area concentration versus time curve AUC IV dose Considerable interpatient variability pharmacokinetic variables exists IV Various metabolites etoposide detection quantitation etoposide dose bioavailability oral etoposide absorption linear doses range clinical use Considerable interpatient intrapatient variability pharmacokinetics oral etoposide evidence etoposide accumulation multiple consecutive doses IV oral route exact roles liver kidney metabolism excretion etoposide uncertain Etoposide schedule-dependent drug clinical studies phase-specific action etoposide widespread use cancer clinical pharmacology drug great clinical importance